Canada Goose (TSX:GOOS) Stock Plummets More Than 15% as Omicron Weighs on Results

Canada Goose stock fell on earnings miss, but it’s a temporary blip, as virus-related disruptions overshadow continued growth and operational excellence.

| More on:
Coronavirus 2019-nCoV Blood Samples Medical Concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Early this morning, Canada Goose Holdings (TSX:GOOS)(NYSE:GOOS) reported lower-than-expected results and lowered its full-year outlook. This came as a huge surprise to the market, and investor have sent the shares down more than 15% this morning.

What happened to Canada Goose stock?

The third quarter of 2022 was impacted by new Omicron variant outbreaks and restrictions. This translated into the lower-than-expected revenue in the quarter. It also translated to a 4.6% reduction in the company’s revenue forecast for the full year. Obviously, this has created a domino effect and a deterioration in all metrics as we move down on the income statement.

The bottom line is that Canada Goose’s EPS expectation for the full year is now 15% lower. The company is calling for EPS to be in the range of $1.02 to $1.11 versus the prior expectation that EPS would come in between $1.17 to $1.33. This is clearly a big blow to the company and the stock.

So what?

Upon closer examination, we can see the Canada Goose is, in part, a victim of its lofty valuations. But this is nothing new. This retailer has been very richly valued since the start of its trading. So, while the company has come in below what was built into its stock price, things are not so bad. In fact, Canada Goose posted a healthy 24% rise in revenue. Similarly, the company saw a 40% increase in EPS and for the full year, EPS is expected to grow by 39%.

So, this leads me to my next point. Basically, valuation is so important. As Canada Goose stock has shown, even a great result can lead to a catastrophic fall if the expectations that are priced into the stock are too high. So, as the stock gets hit, let’s keep in mind that this is still a great business. The issue here is that valuation needs to be brought back down closer to reality. The stock price action today is doing just that, so we can now wait patiently for a good entry point into a great business.

Now what?

As investors digest this earnings miss and these lowered expectations, we have to remember the growth that Canada Goose continues to experience. As per the CEO, the company is “on track to exceed $1 billion in revenue for the first time ever”.

The earnings miss is a result of a temporary event, that is, the omicron virus. This type of miss usually results in a good opportunity to buy. Canada Goose stock’s valuation is falling. The company is already recovering from the temporary blip that the virus has created. Keep in mind that while the stock remains expensive on today’s earnings, it only trades at 20 times 2023 expected earnings.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Coronavirus

Business success with growing, rising charts and businessman in background
Coronavirus

1 Growth Stock Every Canadian Investor Should Consider Right Now

This growth stock saw shares pop 10% on June 20, as one analyst stated there is a significant opportunity to…

Read more »

Aircraft wing plane
Coronavirus

Bombardier Stock Merge: What it Means for Investors

Bombardier (TSX:BBD.B) stock went through a reverse stock split on June 13, turning 25 shares into one in one swift…

Read more »

Aircraft wing plane
Coronavirus

Air Canada (TSX:AC) Stock: Ready to Take Off?

While Air Canada is handling what it can control really well, there are many worsening macro headwinds that will likely…

Read more »

rail train
Coronavirus

Bull or Bear: Why Analysts Changed Their Tune on Aecon Stock

Analysts had been champing at the bit for the construction company, but the tides have turned.

Read more »

Biotech stocks
Coronavirus

Is Bellus Health Stock Still a Buy After 30% Earnings Jump?

The biotech continues to make progress on obtaining FDA approval for its chronic-cough therapy.

Read more »

grow dividends
Coronavirus

Goodfood Stock Likely to Double in 2022!

Goodfood (TSX:FOOD) stock has had a huge rise and fall in the last few years. But at $1.85 a share,…

Read more »

grow dividends
Coronavirus

Canfor Stock Pops 5% as Sales Climb 15% YOY

Canfor (TSX:CFP) stock remained positive about its future in the global lumber market after profits climb 15% year over year.

Read more »

edit Safety First illustration
Coronavirus

2 Crash-Proof TSX Stocks I’d Buy With $5,000

These two TSX stocks have proven they can handle this economic downturn and likely will continue to be safe far…

Read more »